Shares of Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the six analysts that are covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company.
STVN has been the topic of several recent analyst reports. Wolfe Research began coverage on Stevanato Group in a research note on Friday. They issued an “outperform” rating and a $28.00 target price on the stock. Bank of America lifted their price objective on Stevanato Group from $24.00 to $26.00 and gave the stock a “buy” rating in a research report on Friday. Finally, Morgan Stanley reaffirmed an “equal weight” rating and issued a $23.00 price target (down previously from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd.
Read Our Latest Analysis on Stevanato Group
Institutional Investors Weigh In On Stevanato Group
Stevanato Group Stock Up 3.7 %
STVN opened at €23.31 ($24.54) on Friday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81. Stevanato Group has a 1 year low of €16.56 ($17.43) and a 1 year high of €34.73 ($36.56). The stock’s 50 day simple moving average is €19.67 and its 200 day simple moving average is €19.68.
Stevanato Group (NYSE:STVN – Get Free Report) last issued its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) earnings per share (EPS) for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The firm had revenue of €277.90 million during the quarter, compared to the consensus estimate of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. The firm’s revenue for the quarter was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.16 EPS. As a group, sell-side analysts anticipate that Stevanato Group will post 0.5 EPS for the current fiscal year.
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Articles
- Five stocks we like better than Stevanato Group
- Learn Technical Analysis Skills to Master the Stock Market
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- How to Find Undervalued Stocks
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Stock Average Calculator
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.